Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 20, Pages 2181-2190
Publisher
Baishideng Publishing Group Inc.
Online
2018-05-28
DOI
10.3748/wjg.v24.i20.2181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetics at the base of alternative splicing changes that promote colorectal cancer
- (2017) Alberto R. Kornblihtt JOURNAL OF CLINICAL INVESTIGATION
- The application and mechanism of PD pathway blockade for cancer therapy
- (2017) Xing Wang et al. POSTGRADUATE MEDICAL JOURNAL
- Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
- (2017) Marc Hennequart et al. Cancer Immunology Research
- Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma
- (2017) Chuangzhong Deng et al. OncoImmunology
- Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
- (2015) Manabu Takamatsu et al. CANCER SCIENCE
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune checkpoints and immunotherapy for colorectal cancer
- (2015) Preet Paul Singh et al. Gastroenterology Report
- Inhibition of COX-2 in Colon Cancer Modulates Tumor Growth and MDR-1 Expression to Enhance Tumor Regression in Therapy-Refractory Cancers In Vivo
- (2015) Mahbuba Rahman et al. NEOPLASIA
- Darmkrebsfrüherkennung
- (2014) H. Brenner et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Current advances in T-cell-based cancer immunotherapy
- (2014) Mingjun Wang et al. Immunotherapy
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- (2011) L Ferdinande et al. BRITISH JOURNAL OF CANCER
- Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
- (2011) Anna M Dahlin et al. MODERN PATHOLOGY
- Colorectal Cancer: National and International Perspective on the Burden of Disease and Public Health Impact
- (2010) Ziad F. Gellad et al. GASTROENTEROLOGY
- The effect of COX-2 inhibitor on capecitabine-induced hand–foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study
- (2010) Rong-Xin Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
- (2009) Yan-Fang Gao et al. Journal of Translational Medicine
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now